The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...

Mothers with MS face longer diagnostic delays than women without children, especially those who are employed or single.

England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...

Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...